Home > News > A TINY Opportunity in Nanosys' News
July 20th, 2007
A TINY Opportunity in Nanosys' News
Venture-capital firm Harris & Harris (Nasdaq: TINY) is a difficult company to follow, because its value resides in the two dozen-plus nanotechnology start-ups in which it has an equity stake.
For a long time, one of its more visible portfolio holdings was Nanosys, a Palo Alto, Calif.-based start-up that many thought would be the first true nanotechnology company to go public.
Well, for a variety of reasons, Nanosys failed to file for an IPO back in 2004, and as a result, it has somewhat unfairly been held up as the poster child for much of the hype that surrounded the field of nanotechnology a few years back.
An article in today's Technology Review, however, reveals that Nanosys is alive and kicking, and it has made deals with both Intel (Nasdaq: INTC) and Micron (NTSE: MU) to begin supplying its metal nanocrystals in next-generation flash memory chips as early as 2009.
Arrowhead to Present at 2015 RBC Capital Markets' Global Healthcare Conference February 17th, 2015
Iran 1st among Islamic Nations in Scientific Production, Nanotechnology February 16th, 2015
Harris & Harris Group Portfolio Company D-Wave Systems Raises an Additional $29 Million (CAD), Closing 2014 Financing at $62 Million (CAD) February 2nd, 2015
Malaysian Nanotechnology Company Nanopac Innovation Ltd. lists on the NSX January 19th, 2015
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Novel Method to Determine Optical Purity of Drug Components March 1st, 2015
Moving molecule writes letters: Caging of molecules allows investigation of equilibrium thermodynamics February 27th, 2015
Untangling DNA with a droplet of water, a pipet and a polymer: With the 'rolling droplet technique,' a DNA-injected water droplet rolls like a ball over a platelet, sticking the DNA to the plate surface February 27th, 2015
Graphene shows potential as novel anti-cancer therapeutic strategy: University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells February 26th, 2015